Search NLS News

AstraZeneca’s Evusheld, a long-acting antibody combination, has been granted marketing authorization in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg. The approval by the European Commission was based on results from the Evusheld clinical […]

The CALLA Phase III trial for AstraZeneca’s Imfinzi given concurrently with chemoradiotherapy (CRT) did not achieve statistical significance for the primary endpoint of improving progression-free survival (PFS) versus CRT alone in the treatment of patients with locally advanced cervical cancer. “CALLA tested a novel immunotherapy approach in locally advanced cervical cancer, a devastating and complex […]

The Regional Health Authorities in Norway has recently decided to reimburse patients who are included in the first expansion cohort in IMPRESS-Norway according to a pay-for-performance model. IMPRESS-Norway is a precision medicine trial that tests approved drugs on new indications based on genetic changes in the patient’s tumor. The study started in April last year, […]

EpiEndo Pharmaceuticals has announced the appointment of Stefan Petursson as Chief Financial Officer (CFO). Stefan Petursson is taking over the role of CFO from Finnur Einarsson who will now focus on his role as Chief Operations Officer (COO). “I am delighted to welcome Stefan to EpiEndo as CFO,” commented Maria Bech, CEO of EpiEndo Pharmaceuticals. […]

This weekend most countries in Europe will spring forward one hour. We take a closer look upon how our inner clock regulates critical functions like behavior, hormone levels, sleep, body temperature and metabolism. Daylight Saving Time (DST) is not removed in 2022 despite the fact that the European Parliament voted to end daylight saving time […]

AstraZeneca’s Evusheld, a long-acting antibody combination, has been recommended for marketing authorization in the EU for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg. People not adequately protected by a COVID-19 vaccine may particularly benefit from pre-exposure prophylaxis with […]

AlzeCure Pharma has announced the outcome of the rights issue with preferential rights for the shareholders that ended on March 22, 2022. The subscription breakdown show that approximately 59.4 percent was subscribed with and without the exercise of subscription rights. Consequently underwriters of the Rights Issue will be allocated approximately 20.8 percent of the Rights […]

Swedish startup Acorai’s vision is to transform heart failure management, and during 2022 the company will have the opportunity to accelerate their solution on the French market. In July 2021 EIT Health launched a new joint accelerator program for Swedish start-ups in digital health and artificial intelligence (AI). At the inauguration of the accelerator program […]

Key2Compliance is expanding outside Sweden’s borders for the first time. Recruitment has already started for the Danish office in Copenhagen, states the company in a press release. ”We already have a number of Danish customers and have completed numerous courses and training there. This was a natural step,” says CEO Jan Hellqvist. Continue the growth […]

XNK Therapeutics has announced that the first patient has been treated in a Phase II clinical study using XNK’s leading autologous natural killer (NK) cell-based candidate drug in combination with Sanofi’s anti-CD38 antibody Sarclisa (Isatuximab). “Having the first patient treated with NK cells in this clinical study is an important milestone in the clinical development […]